168 related articles for article (PubMed ID: 16849545)
1. Physical and functional interactions between Cas and c-Src induce tamoxifen resistance of breast cancer cells through pathways involving epidermal growth factor receptor and signal transducer and activator of transcription 5b.
Riggins RB; Thomas KS; Ta HQ; Wen J; Davis RJ; Schuh NR; Donelan SS; Owen KA; Gibson MA; Shupnik MA; Silva CM; Parsons SJ; Clarke R; Bouton AH
Cancer Res; 2006 Jul; 66(14):7007-15. PubMed ID: 16849545
[TBL] [Abstract][Full Text] [Related]
2. Signal transducer and activator of transcription 5b, c-Src, and epidermal growth factor receptor signaling play integral roles in estrogen-stimulated proliferation of estrogen receptor-positive breast cancer cells.
Fox EM; Bernaciak TM; Wen J; Weaver AM; Shupnik MA; Silva CM
Mol Endocrinol; 2008 Aug; 22(8):1781-96. PubMed ID: 18550772
[TBL] [Abstract][Full Text] [Related]
3. Estrogen negatively regulates epidermal growth factor (EGF)-mediated signal transducer and activator of transcription 5 signaling in human EGF family receptor-overexpressing breast cancer cells.
Boerner JL; Gibson MA; Fox EM; Posner ED; Parsons SJ; Silva CM; Shupnik MA
Mol Endocrinol; 2005 Nov; 19(11):2660-70. PubMed ID: 15976008
[TBL] [Abstract][Full Text] [Related]
4. Expression of a phosphorylated p130(Cas) substrate domain attenuates the phosphatidylinositol 3-kinase/Akt survival pathway in tamoxifen resistant breast cancer cells.
Soni S; Lin BT; August A; Nicholson RI; Kirsch KH
J Cell Biochem; 2009 May; 107(2):364-75. PubMed ID: 19330798
[TBL] [Abstract][Full Text] [Related]
5. Tamoxifen treatment promotes phosphorylation of the adhesion molecules, p130Cas/BCAR1, FAK and Src, via an adhesion-dependent pathway.
Cowell LN; Graham JD; Bouton AH; Clarke CL; O'Neill GM
Oncogene; 2006 Dec; 25(58):7597-607. PubMed ID: 16799644
[TBL] [Abstract][Full Text] [Related]
6. A novel association between p130Cas and resistance to the chemotherapeutic drug adriamycin in human breast cancer cells.
Ta HQ; Thomas KS; Schrecengost RS; Bouton AH
Cancer Res; 2008 Nov; 68(21):8796-804. PubMed ID: 18974122
[TBL] [Abstract][Full Text] [Related]
7. Acquisition of epithelial-mesenchymal transition phenotype in the tamoxifen-resistant breast cancer cell: a new role for G protein-coupled estrogen receptor in mediating tamoxifen resistance through cancer-associated fibroblast-derived fibronectin and β1-integrin signaling pathway in tumor cells.
Yuan J; Liu M; Yang L; Tu G; Zhu Q; Chen M; Cheng H; Luo H; Fu W; Li Z; Yang G
Breast Cancer Res; 2015 May; 17(1):69. PubMed ID: 25990368
[TBL] [Abstract][Full Text] [Related]
8. Signal transducer and activator of transcription 5b: a new target of breast tumor kinase/protein tyrosine kinase 6.
Weaver AM; Silva CM
Breast Cancer Res; 2007; 9(6):R79. PubMed ID: 17997837
[TBL] [Abstract][Full Text] [Related]
9. Long-term treatment with tamoxifen facilitates translocation of estrogen receptor alpha out of the nucleus and enhances its interaction with EGFR in MCF-7 breast cancer cells.
Fan P; Wang J; Santen RJ; Yue W
Cancer Res; 2007 Feb; 67(3):1352-60. PubMed ID: 17283173
[TBL] [Abstract][Full Text] [Related]
10. Activation of c-Src/HER1/STAT5b and HER1/ERK1/2 signaling pathways and cell migration by hexachlorobenzene in MDA-MB-231 human breast cancer cell line.
Pontillo CA; García MA; Peña D; Cocca C; Chiappini F; Alvarez L; Kleiman de Pisarev D; Randi AS
Toxicol Sci; 2011 Apr; 120(2):284-96. PubMed ID: 21205633
[TBL] [Abstract][Full Text] [Related]
11. BCAR3 regulates Src/p130 Cas association, Src kinase activity, and breast cancer adhesion signaling.
Schuh NR; Guerrero MS; Schrecengost RS; Bouton AH
J Biol Chem; 2010 Jan; 285(4):2309-17. PubMed ID: 19940159
[TBL] [Abstract][Full Text] [Related]
12. Insulin-like growth factor-I receptor signaling in tamoxifen-resistant breast cancer: a supporting role to the epidermal growth factor receptor.
Knowlden JM; Hutcheson IR; Barrow D; Gee JM; Nicholson RI
Endocrinology; 2005 Nov; 146(11):4609-18. PubMed ID: 16037379
[TBL] [Abstract][Full Text] [Related]
13. Inhibition of erbB receptor (HER) tyrosine kinases as a strategy to abrogate antiestrogen resistance in human breast cancer.
Kurokawa H; Arteaga CL
Clin Cancer Res; 2001 Dec; 7(12 Suppl):4436s-4442s; discussion 4411s-4412s. PubMed ID: 11916237
[TBL] [Abstract][Full Text] [Related]
14. Regulation of p130(Cas)/BCAR1 expression in tamoxifen-sensitive and tamoxifen-resistant breast cancer cells by EGR1 and NAB2.
Kumbrink J; Kirsch KH
Neoplasia; 2012 Feb; 14(2):108-20. PubMed ID: 22431919
[TBL] [Abstract][Full Text] [Related]
15. Inhibition of STAT3 enhances sensitivity to tamoxifen in tamoxifen-resistant breast cancer cells.
Moon SY; Lee H; Kim S; Hong JH; Chun SH; Lee HY; Kang K; Kim HS; Won HS; Ko YH
BMC Cancer; 2021 Aug; 21(1):931. PubMed ID: 34407787
[TBL] [Abstract][Full Text] [Related]
16. Breast cancer antiestrogen resistance-3 expression regulates breast cancer cell migration through promotion of p130Cas membrane localization and membrane ruffling.
Schrecengost RS; Riggins RB; Thomas KS; Guerrero MS; Bouton AH
Cancer Res; 2007 Jul; 67(13):6174-82. PubMed ID: 17616674
[TBL] [Abstract][Full Text] [Related]
17. Modulation of signal transducer and activator of transcription 5b activity in breast cancer cells by mutation of tyrosines within the transactivation domain.
Weaver AM; Silva CM
Mol Endocrinol; 2006 Oct; 20(10):2392-405. PubMed ID: 16772534
[TBL] [Abstract][Full Text] [Related]
18. Mechanisms of CAS substrate domain tyrosine phosphorylation by FAK and Src.
Ruest PJ; Shin NY; Polte TR; Zhang X; Hanks SK
Mol Cell Biol; 2001 Nov; 21(22):7641-52. PubMed ID: 11604500
[TBL] [Abstract][Full Text] [Related]
19. Autocrine WNT signaling contributes to breast cancer cell proliferation via the canonical WNT pathway and EGFR transactivation.
Schlange T; Matsuda Y; Lienhard S; Huber A; Hynes NE
Breast Cancer Res; 2007; 9(5):R63. PubMed ID: 17897439
[TBL] [Abstract][Full Text] [Related]
20. Protein pathway activation mapping reveals molecular networks associated with antiestrogen resistance in breast cancer cell lines.
van Agthoven T; Godinho MF; Wulfkuhle JD; Petricoin EF; Dorssers LC
Int J Cancer; 2012 Nov; 131(9):1998-2007. PubMed ID: 22328489
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
